TickerFacts.

Bioventus Inc. (BVS): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.56M
Year ended 2025-12-31
$2.59M
Trailing 12 months to 2026-06-27
+20.1%
3-year compound annual growth
$16.58M2019-12-31: $2.34M2020-12-31: $16.58M2021-12-31: $13.52M2022-12-31: $1.48M2023-12-31: $7.36M2024-12-31: $1.01M2025-12-31: $2.56M$2.56M
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.56M+154.7%2026-03-05, From 2025-01-01
2024-12-31$1.01M-86.3%2026-03-05, From 2024-01-01
2023-12-31$7.36M+398.1%2026-03-05, From 2023-01-01
2022-12-31$1.48M-89.1%2025-03-11, From 2022-01-01
2021-12-31$13.52Mn/c2024-03-12, From 2021-01-01
2020-12-31$16.58M+607.9%2023-03-31, From 2020-01-01
2019-12-31$2.34Mn/a2022-03-11, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Bioventus Inc. (BVS)2025-12-31$2.56M+154.7%
UFP Technologies Inc (UFPT)2024-12-31$9.66M-8.0%
AtriCure, Inc. (ATRC)2025-12-31$9.05M-21.0%
Glaukos Corp (GKOS)2025-12-31$7.67M+21.7%
NovoCure Ltd (NVCR)2025-12-31$26.65M-37.8%
Artivion, Inc. (AORT)2025-12-31$39.04M+249.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$46.34M+36.5%
Alphatec Holdings, Inc. (ATEC)2025-12-31$42.45M-49.0%
Accuray Inc (ARAY)2026-06-30$5.86M+37.2%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗